【レポートの概要（一部）】
1. Executive Summary
2. Introduction to the Industry
2.1 Industry Definition
2.2 Market Profile
2.3 Market Statistics
2.4 Industry Performance
2.5 Market Segmentation
2.6 Competitive Landscape
2.7 Difference between Biotech & Pharmaceutical Industries
2.8 Biotechnology as a Business
2.9 Global Financing
2.10 Global Direct Investments
2.11 Buyer Power
2.12 Supplier Power
2.13 Market Entry
2.14 Rivalry in the Industry
2.15 Presence of Substitutes
2.16 Global Biotechnology Market: Future Perspective
3. Applications of Biotechnology
3.1 Overview
3.2 Applications in Medicine
3.3 Applications in Pharmacogenomics
3.4 Development of Pharmaceutical Products
3.5 Role of Biotechnology in Genetic Testing
3.6 Role of Biotechnology in Gene Therapy
3.7 Role of Biotechnology in Cloning
3.8 Agricultural Applications
3.9 Use of Biotechnology in Bioremediation and Biodegradation
4. Industry Segmentation
4.1 Bioinformatics
4.2 Genomics
4.3 Pharmacogenomics
4.4 Proteomics
5. Biotech Industry and Drug Development
6. Trends in the Industry
6.1 Overview
6.2 Bioinformatics
6.3 Biosensor Technology
6.4 Cell Culture Technology
6.5 Cloning Technology
6.5.1 Molecular Cloning
6.5.2 Cellular Cloning
6.5.3 Animal Cloning
6.6 DNA Chip Technology
6.7 Microarrays
6.7.1 DNA Microarrays
6.7.2 Protein Microarrays
6.7.3 Tissue Microarrays
6.7.4 Whole-Cell Microarrays
6.8 Monoclonal Antibody Technologies
6.9 Nanobiotechnology
6.10 Protein Engineering Technology
6.11 Recombinant DNA Technology
6.12 Hybrid Technology
6.13 Tissue Engineering Technology
7. Challenges Facing the Industry
7.1 Overview
7.2 Globalization of the Industry
7.3 Pressure to Improve Productivity
7.4 Energy Availability
7.5 Integrity of the Supply Chain
7.6 Decoding the Causes of Diseases
7.7 Personalized Medicine
7.8 Biosimilars/Biobetters
7.9 Right to Information
7.10 Smarter & More Cooperative Regulations
7.11 New Methods of Manufacturing
7.12 Gaining the Investor Confidence
7.13 Regulatory Barriers
7.14 Issues with Patents and Intellectual Property
7.15 Financial Issues
7.16 Challenges in Developing Countries
7.17 Issues with Genetic Manipulation
7.18 Water Issues
7.19 Issues with Commercial Product Recovery
7.20 Issues with Extensive Use of Biocatalysts
7.21 Public Outcry
8. Opportunities in Biosimilars
9. Regulation and Intellectual Property in Biotechnology
9.1 Role of Regulation
9.2 Role of Public Policy in Biotech Innovation
9.3 Role of Intellectual Property
10. Impact of the Economic Recession on the Global Biotechnology Industry
11. Biotechnology Market in Australia
11.1 Market Profile
11.2 Market Segments
11.2.1 Human Therapeutics and Diagnostics
11.2.2 Agricultural Biotechnology
11.2.3 Environmental Biotechnology
11.2.4 Food Processing
11.3 Market Size
11.4 Growth Rate
11.5 Market Drivers
11.6 Regulatory Framework
12. Biotechnology Market in Belgium
12.1 Market Statistics
12.2 Market Segmentation
12.3 Competitive Landscape
12.4 Future Perspective
13. Biotechnology Market in Brazil
13.1 Market Profile
13.2 Boom in Agricultural Biotechnology
13.3 Use of Biotechnology in the Biofuels Industry
13.4 Investment in Brazil’s Biotechnology Market
13.5 Regulatory Barriers
13.6 Future Perspective
14. Biotechnology Market in Canada
14.1 Market Statistics
14.2 Market Segmentation
14.3 Competitive Landscape
14.4 Future Perspective
15. Biotechnology Market in China
15.1 Market Profile
15.2 Market Statistics
15.3 Market Segmentation
15.4 Application Sectors of Biotechnology in China
15.4.1 Biomedicine
15.4.2 Bioagriculture
15.4.3 Industrial Biotechnology
15.4.4 Bioenergy
15.4.5 Bioenvironment
15.5 Regulations Impacting the Industry
15.6 Reforms Accelerating Growth of Biotech
15.7 Impact of the Economic Recession on China’s Biotech Industry
15.8 Public-Private Sector Interaction
15.9 Venture Capital in China’s Biotechnology Market
15.10 Role of Science Parks
15.11 Competitive Landscape
15.12 Future Perspective
16. Biotechnology Market in Cuba
17. Biotechnology Market in France
17.1 Market Statistics
17.2 Market Segmentation
17.3 Competitive Landscape
17.4 Future Perspective
18. Biotechnology Market in Germany
18.1 Market Profile
18.2 Market Statistics
18.3 Market Segmentation
18.4 Competitive Landscape
18.5 Future Perspective
19. Biotechnology Market in India
19.1 Market Profile
19.2 Segment Analysis
19.2.1 Biopharmaceuticals
19.2.2 Bioservices
19.2.3 Bioagri
19.2.4 Bioindustrial
19.2.5 Bioinformatics
19.3 Reforms Accelerating Growth of Biotech
19.4 Issue of Bt Brinjal
19.5 Growth in Stem Cell Research
19.6 Emergence of Biosimilars
19.7 Impact of the Economic Recession on India’s Biotech Industry
19.8 Investment in India’s Biotechnology Market
19.9 Industry Strategies
19.9.1 Public-Private Partnerships
19.9.2 Requirement of Higher Venture Capital Funding in India
19.9.3 Moving to a Higher Value Chain
19.9.4 Enhancing Biotech Applications
19.9.5 Lucrative Domestic Market
19.9.6 Development of Skilled Manpower
19.9.7 Shortage of Manpower
19.9.8 Relationship between Pharma and Biotech Sectors
19.9.9 Boosting North-South Collaborations
19.9.10 Requirement of Innovation in Funding Models
19.9.11 Cluster Development
19.10 Future Perspective
20. Biotechnology Market in Italy
20.1 Market Statistics
20.2 Market Segmentation
20.3 Competitive Landscape
20.4 Future Perspective
21. Biotechnology Market in Japan
21.1 Market Profile
21.2 Market Statistics
21.3 Market Segmentation
21.4 Impact of the Economic Recession on Japan’s Biotech Industry
21.5 Investment in Japan’s Biotechnology Market
21.6 Competitive Landscape
21.7 Future Perspective
22. Biotechnology Market in Malaysia
22.1 Market Profile
22.2 Healthcare Biotechnology Market
22.3 Industrial Biotechnology Market
22.4 Investment in Malaysia’s Biotechnology Market
22.5 Funding Issues
22.6 Regulatory Framework
22.7 Future Perspective
23. Biotechnology Market in the Netherlands
23.1 Market Statistics
23.2 Market Segmentation
23.3 Competitive Landscape
23.4 Future Perspective
24. Biotechnology Market in New Zealand
24.1 Market Profile
24.2 Venture Capital in New Zealand’s Biotechnology Market
24.3 Angel Investment: A Latest Trend
24.4 Investment in New Zealand’s Biotechnology Market
24.5 Reforms Accelerating Growth of Biotech
24.6 Future Perspective
25. Biotechnology Market in Pakistan
26. Biotechnology Market in Romania
27. Biotechnology Market in Singapore
27.1 Market Profile
27.2 Commercial Manufacturing in Singapore
27.3 Growth in Biotech R&D
27.4 Impact of the Economic Recession on Singapore’s Biotech Industry
27.5 Future Perspective
28. Biotechnology Market in South Korea
29. Biotechnology Market in Spain
29.1 Market Statistics
29.2 Market Segmentation
29.3 Competitive Landscape
29.4 Future Perspective
30. Biotechnology Market in Sri Lanka
31. Biotechnology Market in Switzerland
31.1 Market Profile
31.2 Growth in Number of Biotech Patents
31.3 Competitive Swiss Biotech Inventions
31.4 Venture Capital in Swiss Biotechnology Market
32. Biotechnology Market in Tanzania
33. Biotechnology Market in United Kingdom
33.1 Market Profile
33.2 Market Statistics
33.3 Market Segmentation
33.4 Competitive Landscape
33.5 Future Perspective
34. Biotechnology Market in the United States
34.1 Market Profile
34.2 Market Statistics
34.3 Market Segmentation
34.4 Competitive Landscape
34.5 Biotech Financing
34.6 Reforms in US Healthcare and Impact on Biotech Companies
34.7 Future Perspective
35. Analysis of Abbott Laboratories
35.1 Company Overview
35.2 Business Segments
35.3 Major Products & Services
35.4 SWOT Analysis
35.4.1 Strengths
35.4.2 Weaknesses
35.4.3 Opportunities
35.4.4 Threats
36. Analysis of Acorda Therapeutics
36.1 Company Overview
36.2 Business Segments
36.3 Major Products & Services
36.4 SWOT Analysis
36.4.1 Strengths
36.4.2 Weaknesses
36.4.3 Opportunities
36.4.4 Threats
37. Analysis of Actelion Ltd
37.1 Company Overview
37.2 Business Segments
37.3 Major Products & Services
37.4 SWOT Analysis
37.4.1 Strengths
37.4.2 Weaknesses
37.4.3 Opportunities
37.4.4 Threats
38. Analysis of Amgen Inc
38.1 Company Overview
38.2 Business Segments
38.3 Major Products & Services
38.4 SWOT Analysis
38.4.1 Strengths
38.4.2 Weaknesses
38.4.3 Opportunities
38.4.4 Threats
39. Analysis of Amylin Pharmaceuticals
39.1 Company Overview
39.2 Business Segments
39.3 Major Products & Services
39.4 SWOT Analysis
39.4.1 Strengths
39.4.2 Weaknesses
39.4.3 Opportunities
39.4.4 Threats
40. Analysis of Astellas Pharma
40.1 Company Overview
40.2 Business Segments
40.3 Major Products & Services
40.4 SWOT Analysis
40.4.1 Strengths
40.4.2 Weaknesses
40.4.3 Opportunities
40.4.4 Threats
41. Analysis of AstraZeneca Plc
41.1 Company Overview
41.2 Business Segments
41.3 Major Products & Services
41.4 SWOT Analysis
41.4.1 Strengths
41.4.2 Weaknesses
41.4.3 Opportunities
41.4.4 Threats
42. Analysis of Biocon Limited
42.1 Company Overview
42.2 Business Segments
42.3 Major Products & Services
43. Analysis of Biogen Idec
43.1 Company Overview
43.2 Business Segments
43.3 Major Products & Services
43.4 SWOT Analysis
43.4.1 Strengths
43.4.2 Weaknesses
43.4.3 Opportunities
43.4.4 Threats
44. Analysis of Celgene Corporation
44.1 Company Overview
44.2 Business Segments
44.3 Major Products & Services
44.4 SWOT Analysis
44.4.1 Strengths
44.4.2 Weaknesses
44.4.3 Opportunities
44.4.4 Threats
45. Analysis of Cephalon Inc
45.1 Company Overview
45.2 Business Segments
45.3 Major Products & Services
45.4 SWOT Analysis
45.4.1 Strengths
45.4.2 Weaknesses
45.4.3 Opportunities
45.4.4 Threats
46. Analysis of Crucell NV
46.1 Company Overview
46.2 Business Segments
46.3 Major Products & Services
46.4 SWOT Analysis
46.4.1 Strengths
46.4.2 Weaknesses
46.4.3 Opportunities
46.4.4 Threats
47. Analysis of CSL Limited
47.1 Company Overview
47.2 Business Segments
47.3 Major Products & Services
47.4 SWOT Analysis
47.4.1 Strengths
47.4.2 Weaknesses
47.4.3 Opportunities
47.4.4 Threats
48. Analysis of Cubist Pharmaceuticals
48.1 Company Overview
48.2 Business Segments
48.3 Major Products & Services
48.4 SWOT Analysis
48.4.1 Strengths
48.4.2 Weaknesses
48.4.3 Opportunities
48.4.4 Threats
49. Analysis of Daiichi Sankyo
49.1 Company Overview
49.2 Business Segments
49.3 Major Products & Services
49.4 SWOT Analysis
49.4.1 Strengths
49.4.2 Weaknesses
49.4.3 Opportunities
49.4.4 Threats
50. Analysis of Enzon Pharmaceuticals
50.1 Company Overview
50.2 Business Segments
50.3 Major Products & Services
50.4 SWOT Analysis
50.4.1 Strengths
50.4.2 Weaknesses
50.4.3 Opportunities
50.4.4 Threats
51. Analysis of Genzyme Corporation
51.1 Company Overview
51.2 Business Segments
51.3 Major Products & Services
51.4 SWOT Analysis
51.4.1 Strengths
51.4.2 Weaknesses
51.4.3 Opportunities
51.4.4 Threats
52. Analysis of Gilead Sciences Inc
52.1 Company Overview
52.2 Business Segments
52.3 Major Products & Services
52.4 SWOT Analysis
52.4.1 Strengths
52.4.2 Weaknesses
52.4.3 Opportunities
52.4.4 Threats
53. Analysis of Hoffmann-La Roche
53.1 Company Overview
53.2 Business Segments
53.3 Major Products & Services
53.4 SWOT Analysis
53.4.1 Strengths
53.4.2 Weaknesses
53.4.3 Opportunities
53.4.4 Threats
54. Analysis of ImmunoGen, Inc
54.1 Company Overview
54.2 Business Segments
54.3 Major Products & Services
54.4 SWOT Analysis
54.4.1 Strengths
54.4.2 Weaknesses
54.4.3 Opportunities
54.4.4 Threats
55. Analysis of LifeCell Corporation
55.1 Company Overview
55.2 Business Segments
55.3 Major Products & Services
56. Analysis of Mitsubishi Tanabe Pharma Corporation
56.1 Company Overview
56.2 Business Segments
56.3 Major Products & Services
56.4 SWOT Analysis
56.4.1 Strengths
56.4.2 Weaknesses
56.4.3 Opportunities
56.4.4 Threats
57. Analysis of OSI Pharmaceuticals
57.1 Company Overview
57.2 Business Segments
57.3 Major Products & Services
57.4 SWOT Analysis
57.4.1 Strengths
57.4.2 Weaknesses
57.4.3 Opportunities
57.4.4 Threats
58. Analysis of Takara Holdings
58.1 Company Overview
58.2 Business Segments
58.3 Major Products & Services
58.4 SWOT Analysis
58.4.1 Strengths
58.4.2 Weaknesses
58.4.3 Opportunities
58.4.4 Threats
59. Analysis of UCB SA
59.1 Company Overview
59.2 Business Segments
59.3 Major Products & Services
59.4 SWOT Analysis
59.4.1 Strengths
59.4.2 Weaknesses
59.4.3 Opportunities
59.4.4 Threats
60. Analysis of Vertex Pharmaceuticals
60.1 Company Overview
60.2 Business Segments
60.3 Major Products & Services
60.4 SWOT Analysis
60.4.1 Strengths
60.4.2 Weaknesses
60.4.3 Opportunities
60.4.4 Threats
61. Analysis of ViroPharma Incorporated
61.1 Company Overview
61.2 Business Segments
61.3 Major Products & Services
61.4 SWOT Analysis
61.4.1 Strengths
61.4.2 Weaknesses
61.4.3 Opportunities
61.4.4 Threats
62. Analysis of ZymoGenetics Inc
62.1 Company Overview
62.2 Business Segments
62.3 Major Products & Services
62.4 SWOT Analysis
62.4.1 Strengths
62.4.2 Weaknesses
62.4.3 Opportunities
62.4.4 Threats
63. Appendix
64. Glossary
【レポート販売概要】
■ タイトル：バイオテクノロジーのグローバル市場動向■ 英文：Global Biotechnology Market
■ 発行日：2014年5月
■ 調査会社：Taiyou Research
■ 商品コード：Taiyou-40619075
■ 調査対象地域：グローバル
- 世界のデジタル・サイネージ市場動向及び予測（2014 – 2020）Digital signage refers to any of the electronic display that broadcasts television programming, menus, information, advertising, and other contents. Digital signs utilizing technologies such as LCD, LED, plasma displays, or projected images to display content is found in both public and private environments, including retail stores, hotels, restaurants, and corporate buildings, amongst other locat …
- 防汚塗料の世界市場：船舶、リグ用途About Antifouling Coatings Antifouling coatings are paints or coatings applied to the hull of a boat, ship, or yacht to reduce the growth of organisms on the part of the ship that is under water and to prevent corrosion of metal hulls. The application of such coatings improves the durability and performance of the vessel. In addition, antifouling coatings are used in fixed and floating offshore oi …
- 世界の自動車用IC電子部品市場About Automotive IC An IC is a set of electronic circuits that function as an amplifier, timer, computer memory, and microprocessor. Semiconductor devices such as microcontrollers are used in vehicles. As semiconductor technology has evolved, it has enabled vehicle manufacturers to put together multiple applications on a single chip to optimize performance. Automotive electronics are used in safet …
- T-Cell Lymphomas：グローバル臨床試験動向（2014年上半期）T-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment statu …
- 医薬品有力企業シリーズ： 眼薬メーカー上位25社分析2016-2026What can be expected from the ophthalmic drugs market? Which companies are going to be most successful in the next 10 years? Which therapeutic areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects in the market. Our 220-page report provides 160 tables, charts, and graphs. Discover the most succ …
- スピルリナ属の世界市場：アルスロスピラプラテンシス、アルスロスピラマキシマSpirulina is a natural algae powder known as cyanobacteria that comprises potent level of proteins, antioxidants, and vitamin B and other nutrients. Spirulina exhibits various benefits such as lowering of LDL and triglyceride levels and anticancer properties. It also reduces blood pressure, is effective against anemia, and improves muscle strength. The global spirulina market generated $348 millio …
- コンシューマIAM（アイデンティティ・アクセス管理）の世界市場予測（～2022年）The consumer Identity and Access Management (IAM) market size is expected to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 17.3% during the forecast period. The major growth drivers of the consumer IAM market include growing concern to manage consumer identity, rise in adoption of Internet of Things (IoT) and smart devices, and need fo …
- Pengrowth Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- 世界のニードルコークス市場2015The Global Needle Coke Industry Report 2015 is a professional and in-depth study on the current state of the Needle Coke industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Needle Coke market analysis is provided for the international markets including development trends, competitive landscape analysis …
- 世界の患者体温管理市場（2014-2018）TechNavio's analysts forecast the Global Patient Temperature Management market to grow at a CAGR of 7.4 percent over the period 2013-2018. One of the key factors contributing to this market’s growth is the increasing incidence of cardiac and CNS disorders. The Global Patient Temperature Management market has also been witnessing an increase in mergers and acquisitions among the leading vendors to …
- Worldwide Handset Shipments, Market Share & Growth Rate by Vendor, Region and Country Q3’2011Worldwide handset shipments reached over 393.96 million units during the third quarter of 2011, representing a Year-over-Year (YoY) growth rate of 14.86 %. While shipment volumes declined in developed markets such as North America and Western Europe, developing markets such as Asia Pacific, Latin & Central America (LACA), and Middle East & Africa (MEA) region experienced a thriving growth in shipm …
- 米国の末梢血管処置用機器市場見通し（～2021）United States Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "United States Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the United States Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection P …
- 欧州の冬服市場2016-2020About Winter Wear in Europe Product sales in this particular market depends on seasons, and is driven by the climatic conditions of a region. Winter seasons that are relatively warmer can hamper the sale of winter wear to a significant extent. The warm winters experienced in late 2015, for example, affected the sale of winter wear considerably, which impacted the business of retailers. Popular fas …
- Unit Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Unit Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- ゴルフツーリズムの世界市場2019-2023About this market Rising adoption of golf tourism in developing countries to drive growth in the market. The penetration of golf tourism in developing countries is also increasing with the popularity of the game in these countries. improved living standards, increased interest in golf, and enhancement of sports facilities are driving the popularity of the game in the region. Technavio’s analysts h …
